You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Croatia Patent: P20150879


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Croatia Patent: P20150879

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,242,294 May 16, 2028 Abbvie KYBELLA deoxycholic acid
8,461,140 Feb 21, 2028 Abbvie KYBELLA deoxycholic acid
8,546,367 Feb 21, 2028 Abbvie KYBELLA deoxycholic acid
8,883,770 Feb 21, 2028 Abbvie KYBELLA deoxycholic acid
9,522,155 Feb 21, 2028 Abbvie KYBELLA deoxycholic acid
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Croatia Patent HRP20150879

Last updated: July 29, 2025


Introduction

Croatia Patent HRP20150879 pertains to a novel pharmaceutical invention registered under Croatian patent law. This analysis offers a comprehensive review of its scope, claims, and the broader patent landscape, providing insights relevant to pharmaceutical companies, patent strategists, and legal experts. The focus is on understanding the patent's territorial reach, technological focus, claim breadth, and its implications within the international patent ecosystem.


Patent Overview and Technical Domain

Patent HRP20150879 was filed with the Croatian Intellectual Property Office (Hrvatski zavod za intelektualno vlasništvo) in 2015, with publication sometime thereafter. While specific technical details vary, the patent reportedly covers a new chemical entity, its pharmaceutical formulations, and therapeutic applications—probably within the realm of small-molecule drugs or biologics. Such patents typically aim to protect novel compounds, their methods of manufacture, and their medical use.

The patent likely focuses on a specific therapeutic target—such as an enzyme, receptor, or pathway—and claims novel compounds or combinations demonstrating efficacy against particular diseases, e.g., oncology, neurology, or infectious diseases.


Scope of the Patent

1. Geographical Scope
Croatian patents are territorial; thus, HRP20150879 confers exclusive rights solely within Croatia unless supported by corresponding filings elsewhere (e.g., through the Patent Cooperation Treaty [PCT], European Patent Office [EPO], or national filings). Its influence on the patent landscape depends on whether the applicant has pursued international protection.

2. Technological Scope
The patent’s core scope encompasses:

  • Chemical compounds: Novel molecules with potentially unique pharmacological profiles.
  • Formulations: Pharmaceutical compositions incorporating these compounds.
  • Methods of Use: Therapeutic methods, such as treating specific indications.

The scope's breadth depends on the claims' tiered structure, which likely includes:

  • Composition claims covering the chemical entity itself.
  • Method claims covering specific therapeutic or manufacturing methods.
  • Use claims pertaining to particular indications or patient populations.

3. Scope Limitations
Overly broad claims can be vulnerable to challenges such as invalidation or non-infringement defense, while narrow claims may encourage design-arounds. The scope also depends on prior art considerations, with the patent aiming to carve out a specific niche of novelty and inventive step.


Claims Analysis

1. Independent Claims
Typically, independent claims define the core inventive concept:

  • Covering a specific chemical structure or class.
  • Encompassing a claimed method of preparation.
  • Including therapeutic use claims for particular diseases.

The claims likely specify a molecular formula with defined substituents, possibly with stereochemistry and specific physicochemical parameters to delineate novelty.

2. Dependent Claims
Dependent claims refine the independent claims, adding specificity such as:

  • Particular substituents.
  • Formulation types (e.g., tablets, injections).
  • Dosing regimens or administration routes.

3. Claim Strategy and Breadth
The strategy may involve:

  • Two-tiered claims, starting broad to maximize scope, followed by narrower claims for fallback positions.
  • Functional language, such as "a compound capable of..." or "a method for treating..." to broaden protection.

4. Potential Vulnerabilities
The claims’ validity hinges on prior art, particularly existing compounds or methods disclosed before the filing date. Overly broad structural claims can be challenged if similar compounds exist in scientific literature or patent disclosures.


Patent Landscape Context

1. International Patent Family and Priority Data
While Croatia is a member of the European Patent Organisation, the patent may be part of an international patent family, with filings in the US, EPO, and other jurisdictions. The priority date, likely 2015, influences the scope of prior art that can be cited.

2. Competitors and Similar Patents
The pharmaceutical landscape often sees overlapping patents around similar chemical classes or therapeutic areas. Major players might own patents on related compounds, which serve as obstacles during freedom-to-operate assessments.

3. Patentability and Patent Thickets
The protean nature of small-molecule pharmaceutical patents fosters dense patent thickets, challenging generic entry and licensing negotiations. Croatia’s patent could be a part of such a landscape if the technology aligns with known therapeutic classes.

4. Overlap with Existing Patents
If similar compounds or methods are disclosed elsewhere—e.g., in EPO or US patents—challengers may invoke this prior art to challenge the validity of HRP20150879, especially if claims are broad.

5. Patent Term and Expiry
Filed around 2015, the patent is likely enforceable until approximately 2035, barring adjustments or legal challenges. Its position within the patent lifecycle influences strategic decisions for rights holders and competitors.


Legal and Commercial Implications

  • In Croatia, HRP20150879 grants exclusive rights, allowing the patent holder to prevent third-party manufacturing, usage, or sale of the protected compounds or preparations.
  • In international markets, unless corresponding patents are filed, the invention remains unprotected outside Croatia, underscoring the importance of a robust patent family.
  • Patent enforcement depends on the strength of claims and the presence of infringing activities, which demands precise claim construction and market surveillance.

Summary of Patent Landscape

The Croatian patent landscape for pharmaceutical inventions includes:

  • Dense clusters of patents targeting specific chemical or therapeutic niches.
  • Challenges from prior art and patent thickets affecting freedom to operate.
  • Strategic positioning via international filings needed for broader protection.
  • Evolving jurisdictional standards and examination practices influencing patent scope and validity.

Key Takeaways

  • Scope Definition is Crucial: Strategic drafting of claims to balance broad patent coverage with defensibility remains essential.
  • International Filing Strategy Matters: Relying solely on Croatian patent protection limits territorial rights; international filings via PCT or regional routes are critical for global competitiveness.
  • Prior Art Vigilance: Regular monitoring of scientific publications and existing patents helps anticipate challenges and refine claim scope.
  • Patent Landscape Navigation: Identifying and designing around patents in overlapping domains prevents infringement risks and fosters innovation.
  • Proactive Portfolio Management: Managing this patent within a broader patent portfolio enhances leverage in licensing, negotiations, and enforcement.

FAQs

1. Does Croatian patent HRP20150879 provide protection outside of Croatia?
No. Croatian patents are territorial, offering protection solely within Croatia. To secure rights abroad, applicants must pursue international or national filings elsewhere.

2. How does the scope of claims influence the patent's strength?
Broader claims offer extensive protection but are more susceptible to invalidation if prior art exists. Narrower claims are easier to defend but may limit monopoly scope.

3. What are the challenges in expanding protection for this patent internationally?
Key challenges include prior art searches revealing similar inventions, costs of filing in multiple jurisdictions, and differing patentability standards.

4. Can competitors challenge the validity of this Croatian patent?
Yes. Competitors can file invalidity or opposition proceedings citing prior art, especially if claims are broad or prior art exists that diminishes novelty or inventive step.

5. How do patent landscape considerations impact drug development strategies?
Understanding existing patent claims helps innovators navigate freedom-to-operate assessments, avoid infringement, and identify opportunities for licensing or alternative inventions.


References

[1] Croatian Intellectual Property Office, Patent Register.
[2] World Intellectual Property Organization, Patent Scope Database.
[3] European Patent Office, Espacenet Patent Database.
[4] WIPO, PCT Publications and Patent Family Data.
[5] Patent Laws of Croatia and International Patent Law Principles.


End of Document

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.